类风湿关节炎治疗反应预测因素:一篇叙述性综述
该叙述性综述总结当前用于预测类风湿关节炎(RA)患者对改善病情抗风湿药治疗反应的生物标志物策略,涵盖临床特征、血清学标志物、细胞因子谱、遗传与转录组特征、免疫细胞表型、滑膜病理类型及微生物组特征等多维度标志物。多数单一标志物预测能力有限,整合多生物学维度标志物并探索新型预测标志物可能提高预测稳健性和准确性,以推进精准医疗。
要点
- 多种类型生物标志物可跨不同治疗药物预测RA治疗反应。
- 多数单一标志物预测能力有限,因RA发病机制复杂且动态。
- 整合多维度标志物或可提高治疗反应预测的稳健性与准确性。
核心结论
- 多数单一生物标志物对RA治疗反应的预测能力有限。
- 结合多个生物学维度的标志物并探索新型预测标志物,可能提高RA治疗反应预测的稳健性和准确性。
研究设计与样本
- 叙述性综述,总结当前预测RA治疗反应的生物标志物策略。
主要发现
- 临床特征、血清学标志物、细胞因子谱、遗传与转录组特征、免疫细胞表型、滑膜病理类型及微生物组特征等多类标志物可能有助于预测RA对不同治疗药物的反应。
临床怎么用
- 当前治疗选择在很大程度上仍依赖经验,部分患者未能达到充分临床反应。
- 在治疗开始前使用可靠生物标志物预测治疗反应,有助于指导个体化治疗决策。
局限性
- 多数单一标志物预测能力有限,部分原因在于RA发病机制的复杂性和动态性。
- 综述未报告具体预测效能数值或验证数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rheumatoid arthritis (RA) is a common autoimmune disease having diverse responses to disease-modifying antirheumatic drugs. Although treat-to-target strategies have improved disease management, therapeutic selection remains largely empirical and a substantial proportion of patients fail to achieve adequate clinical response to their therapies. Therefore, reliable biomarkers capable of predicting treatment response before therapy initiation are urgently needed to guide personalised treatment decisions. Current evidence suggests that multiple categories of biomarkers may contribute to the prediction of treatment responses across different therapeutic agents in RA, including clinical characteristics, serological markers, cytokine profiles, genetic and transcriptomic signatures, immune-cell phenotypes, synovial pathotypes and microbiome features. This review summarises current biomarker strategies for predicting therapeutic response in RA and discusses their potential utility in improving precision medicine. However, most individual biomarkers show limited predictive power, partly due to the complex and dynamic nature of RA pathogenesis. Combining biomarkers from multiple biological dimensions, together with the continued exploration of novel predictive markers, may improve the robustness and accuracy of treatment response prediction in RA.
引用
- Sun Y, Stradner MH, Fessler J, et al. Predictors of treatment response in rheumatoid arthritis: a narrative review. RMD Open. 2026. PMID: 42933792. doi:10.1136/rmdopen-2026-007225
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。